P1236EFFECTS OF SACUBITRIL-VALSARTAN IN HEART FAILURE WITH PRESERVED EJECTION FRACTION IN PATIENTS UNDERGOING PERITONEAL DIALYSIS

• Published in: Nephrology, dialysis, transplantation Vol. 35; no. Supplement_3
• Main Authors: Fu, Sha, Xu, Zhenjian, Lin, Baojuan, Chen, Junzhe, Huang, Qiuyan, Xu, Yanchun, Xu, Anping, Chen, Yangxin, Tang, Ying
• Format: Journal Article
• Language: English
• Published: Oxford University Press 01.06.2020

Abstract Background and Aims Angiotensin receptor–neprilysin inhibitor (ARNI) sacubitril–valsartan is a landmark drug in heart failure with reduced ejection fraction (HFrEF), however, it remains unclear in patients with heart failure with preserved ejection fraction (HFpEF), especially the data of A...